Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Applicability of Liquid Biopsy in Intermediate and Malignant Cartilaginous Neoplasms - A Prospective Cohort Study

NCT07492823 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT07492823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07492823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Applicability of Liquid Biopsy in Intermediate and Malignant Cartilaginous Neoplasms - A Prospective Cohort Study
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2026
Completion date
May 31, 2030
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chondrosarcoma of the bone